Navigation Links
Solid-pseudopapillary neoplasm of the pancreas or pancreatic endocrine tumor?
Date:3/17/2010

Solid-pseudopapillary neoplasm (SPN) of the pancreas is relatively rare. There are some similarities between SPN and pancreatic endocrine tumor (PET), especially the non-functioning ones, in clinical and pathological manifestations. Even the results of immunohistochemistry reported in the literature showed that the expression profiles of the two tumors overlapped, which sometimes results in difficulty distinguishing the two entities. In recent years, studies have shown that the vast majority of SPN harbor a point mutation on exon 3 of β-catenin gene, which has not yet been discovered in other pancreas tumors.

A research article published on February 28, 2010 in the World Journal of Gastroenterology addresses this question. A total of 24 cases pathologically diagnosed as SPN or PET, including 10 SPN and 14 PET, were reviewed.

Their results showed SPN of the pancreas, compared with PET, is a cystic-solid or cystic tumor with a larger size mostly seen in young women, and has the morphological features of hemorrhage and necrosis on the cut surface and exclusive pseudopapillary structures on light microscopy caused by cellular dyscohesive degeneration. If necessary, immunostaining of b-catenin and E-cadherin is quite helpful to make the differential diagnosis.


'/>"/>

Contact: Ye-Ru Wang
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. A long-term survival offered by resection of solid-pseudopapillary tumor of the pancreas?
2. What are simple ways to judge the efficacy of 5-fluorouracil in colonic neoplasm?
3. Fudan-Cinpathogen Study Shows Chronic Lymphoid Neoplasms are More Common in Shanghai Than Thought
4. Imaging features of intraductal papillary mucinous neoplasms of the pancreas
5. Circulating fats kill transplanted pancreas cells, study shows
6. Pancreas May Be Key to Pregnancy-Linked Diabetes
7. Stem Cells Finally Found in Pancreas
8. A tumor of the pancreas mimicked by colonic duplication?
9. Laparoscopic Surgery on Pancreas Has Fewer Complications
10. Minimally invasive pancreas surgery leads to fewer complications, study finds
11. Combo Kidney-Pancreas Transplant Boosts Survival in Diabetics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman ... Van Allen have signed a joint enrollment and degree completion agreement. The ... associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students to ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , ... Dover, NH to direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated ... hour from Boston. , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We ...
(Date:2/5/2016)... ... 05, 2016 , ... Regular gym users know the routine: each January, they ... access the treadmills. It’s a predictable trend. After the excesses of November and December, ... shape by joining gyms, starting new walking or running routines, or signing up for ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... in the 2015 Best in KLAS: Software & Services for HIT Implementation Support ... in KLAS report independently ranks vendor performance by healthcare executives, managers and clinicians ...
(Date:2/5/2016)... WORCESTER, MA (PRWEB) , ... February 05, 2016 , ... ... latest in tattoo technology, the PicoSure. Designed to provide the most effective tattoo removal ... cutting-edge option with unmatched results. , Developed by Cynosure, the PicoSure has been approved ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Edwards Lifesciences ... patient-focused innovations for structural heart disease and critical care ... accelerated share repurchase (ASR) agreement with Morgan Stanley & ... stock.  This repurchase is part of the Company,s previously ... the Company,s common stock.  --> ...
(Date:2/4/2016)... , Feb. 4, 2016 Wegener ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline ... Wegener Polyangiitis,s therapeutic pipeline. This report provides ... Polyangiitis, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ...
(Date:2/4/2016)... 2016  Omnicell, Inc. (NASDAQ: OMCL ), a leading ... systems, today announced results for its fiscal year and ... --> GAAP results: Revenue for the ... million or 4.1% from the third quarter of 2015, ... quarter of 2014. Revenue for the year ended December 31, ...
Breaking Medicine Technology: